Charles River Laboratories | CRL - Srodki Pieniężne I Ekwiwalent

Cena Akcji
166.96
Dzienna Zmiana
3.12 1.90%
Miesięcznie
-3.21%
Rocznie
42.84%
Q2 Prognozy TE
166.17




Srodki Pieniężne I Ekwiwalent Zmiana Data
Agilent USD 1.76B 31M 2025-12
Align Technology USD 1.09B 90.32M 2025-12
Bio-Rad Laboratories USD 529.8M 134M 2025-12
Bruker USD 293.1M 201.1M 2025-09
Cardinal Health USD 3.94B 1.16B 2026-03
Charles River Laboratories USD 213.77M 6.67M 2025-12
Cigna USD 7.68B 1.65B 2025-12
Concord Medical Services Hldg CNY 243.38M 85.1M 2023-06
CVS Health USD 8.45B 645M 2025-12
Danaher USD 5.7B 1.09B 2026-03
Dentsply International USD 326M 37M 2025-12
Elevance Health USD 9.66B 166M 2026-03
Galapagos EUR 87.87M 23.41M 2025-12
Humana USD 4.95B 751M 2026-03
Illumina USD 1.42B 368M 2025-12
Incyte USD 4.02B 435.22M 2026-03
Intrexon USD 9.34M 1.77M 2024-06
IQVIA Holdings USD 1.98B 166M 2025-12
Laboratory Of America USD 532.3M 65.8M 2025-12
Lonza CHF 719M 188M 2025-12
McKesson USD 2.96B 1.05B 2025-12
Merck EUR 2.25B 1.08B 2025-09
Mettler Toledo International USD 69.06M 7.24M 2025-09
Novartis USD 11.44B 1.88B 2025-12
Pfizer USD 1.34B 295M 2025-09
Quest Diagnostics USD 393M 27M 2026-03
Revvity USD 919.86M 11.53M 2025-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
United Therapeutics USD 1.56B 217M 2025-12
UnitedHealth USD 31.23B 3.11B 2026-03
Veradigm USD 492.6M 7.57M 2022-09
Waters USD 587.83M 128.71M 2025-12
West Pharmaceutical Services USD 521.4M 269.9M 2026-03